<SEC-DOCUMENT>0001628280-20-015492.txt : 20201104
<SEC-HEADER>0001628280-20-015492.hdr.sgml : 20201104
<ACCEPTANCE-DATETIME>20201104160657
ACCESSION NUMBER:		0001628280-20-015492
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20201104
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201104
DATE AS OF CHANGE:		20201104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		201286701

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgmo-20201104.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:e4022795-ce74-4d3a-8965-24867b4d211d,g:c6ee3928-e402-4019-a15d-5a85550843c8,d:8067b3b68bea405fb06f65a0a024365f--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20201104</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl80L2ZyYWc6ZDc4MzljNzY1MDhkNDg3NWI1ZTVlMDU0YmNhMWRiZjIvdGFibGU6ZWJkYWVmNTliZjgwNDgzYTlmZjkwZWY4MDkyM2M3YWIvdGFibGVyYW5nZTplYmRhZWY1OWJmODA0ODNhOWZmOTBlZjgwOTIzYzdhYl8zLTEtMS0xLTA_9826437a-1e2c-4520-976e-b4ceed4088d5">0001001233</ix:nonNumeric><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl80L2ZyYWc6ZDc4MzljNzY1MDhkNDg3NWI1ZTVlMDU0YmNhMWRiZjIvdGFibGU6ZWJkYWVmNTliZjgwNDgzYTlmZjkwZWY4MDkyM2M3YWIvdGFibGVyYW5nZTplYmRhZWY1OWJmODA0ODNhOWZmOTBlZjgwOTIzYzdhYl80LTEtMS0xLTA_95b2eb4f-4319-4aad-8038-1b2ace49b119">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgmo-20201104.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-04</xbrli:startDate><xbrli:endDate>2020-11-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8067b3b68bea405fb06f65a0a024365f_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl84Ng_2dde4df0-2bff-4ccb-ad8b-007c65af9146">8-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yMTk5MDIzMjU4MTY2_cbc41239-0fa3-4d80-9cc3-e1be389a5fc4">November&#160;4, 2020</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yMzg_3b3566af-0939-4468-8dfe-ee2f467a2a42">SANGAMO THERAPEUTICS, INC.</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:30.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.674%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6ZjEzMGIwYzQwMDJkNGRmZWI0ZGRkNTRjODdlY2RhNjgvdGFibGVyYW5nZTpmMTMwYjBjNDAwMmQ0ZGZlYjRkZGQ1NGM4N2VjZGE2OF8xLTAtMS0xLTA_7ad9bf76-f151-4bb6-a710-659f2a841ae7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6ZjEzMGIwYzQwMDJkNGRmZWI0ZGRkNTRjODdlY2RhNjgvdGFibGVyYW5nZTpmMTMwYjBjNDAwMmQ0ZGZlYjRkZGQ1NGM4N2VjZGE2OF8xLTItMS0xLTA_c24bb2b0-5ea3-4c18-ac81-c2b21613b62a">000-30171</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6ZjEzMGIwYzQwMDJkNGRmZWI0ZGRkNTRjODdlY2RhNjgvdGFibGVyYW5nZTpmMTMwYjBjNDAwMmQ0ZGZlYjRkZGQ1NGM4N2VjZGE2OF8xLTQtMS0xLTA_900f044d-1ba2-43ff-99a7-95320fa1a5e7">68-0359556</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>ID Number)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yNTc2_87b69875-8953-429a-a697-a2d631a32276">7000 Marina Blvd.</ix:nonNumeric>, <ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yNTc3_887e087a-8895-46a0-83b4-96cefeaa35db">Brisbane</ix:nonNumeric>, <ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8zMzE_456403b8-e420-40c5-9a4a-927fe012f6b2">California</ix:nonNumeric> <ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yNTc4_4ea607b5-4644-4161-b84d-de23038f2a98">94005</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8zOTQ_603a9e8d-9a33-467d-8473-65997b048e62">510</ix:nonNumeric>) <ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8zOTg_363f91f6-ddb9-462c-b3d1-8e9ec848de48">970-6000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)&#160;</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Former Name or Former Address, if Changed Since Last Report)&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Y2FjNjYzNTIxYTA5NDBhZDk4Mjc0ZGE4M2FlZmIyOTcvdGFibGVyYW5nZTpjYWM2NjM1MjFhMDk0MGFkOTgyNzRkYTgzYWVmYjI5N18wLTAtMS0xLTA_cc643a71-56f5-4669-9f1e-ddf62e927558">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6OTU0ZDA0ZGVlNDk1NGQyZDkzZDY4MzQ1OWJhNDEzMzEvdGFibGVyYW5nZTo5NTRkMDRkZWU0OTU0ZDJkOTNkNjgzNDU5YmE0MTMzMV8wLTAtMS0xLTA_f017e7ae-f984-4e05-b313-1d7f758d625f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:6.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6NjlhNGY4NWY0ODFkNDA3YTkzMzI5NDkxZmQ4NThlNDkvdGFibGVyYW5nZTo2OWE0Zjg1ZjQ4MWQ0MDdhOTMzMjk0OTFmZDg1OGU0OV8wLTAtMS0xLTA_51a5eb70-98b9-4776-9e92-7d35c655a77d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:6.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6NmMyOWM5Zjg5YjdkNDJkZTg5YTNjMzgwNGY3MWEwODEvdGFibGVyYW5nZTo2YzI5YzlmODliN2Q0MmRlODlhM2MzODA0ZjcxYTA4MV8wLTAtMS0xLTA_01f4fe63-ba16-43ec-9f9a-a4fc828f9f94">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:27.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.842%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Zjk0NmJjZGQ5ODNkNDVmZTk4ZDA0MWE4NjkzNWU5NjcvdGFibGVyYW5nZTpmOTQ2YmNkZDk4M2Q0NWZlOThkMDQxYTg2OTM1ZTk2N18yLTAtMS0xLTA_5ab96040-29fd-48a2-90d4-05c5668c89a6">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Zjk0NmJjZGQ5ODNkNDVmZTk4ZDA0MWE4NjkzNWU5NjcvdGFibGVyYW5nZTpmOTQ2YmNkZDk4M2Q0NWZlOThkMDQxYTg2OTM1ZTk2N18yLTItMS0xLTA_aeae7609-05cc-4224-9a76-52047445119c">SGMO</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Zjk0NmJjZGQ5ODNkNDVmZTk4ZDA0MWE4NjkzNWU5NjcvdGFibGVyYW5nZTpmOTQ2YmNkZDk4M2Q0NWZlOThkMDQxYTg2OTM1ZTk2N18yLTQtMS0xLTA_38d79d07-69c3-4346-b2a8-b00cf53b947d">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter). </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8xMDUy_149ed3db-09e0-45f7-8d72-ceb94408d40f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;4, 2020, Sangamo Therapeutics, Inc. (&#8220;Sangamo&#8221;) issued a press release announcing its financial results for the quarter ended September&#160;30, 2020 (the &#8220;Press Release&#8221;).</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Press Release is furnished hereto as Exhibit 99.1 and is incorporated by reference herein. The information contained in this Item 2.02 and in the Press Release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the Press Release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference into any filing with the SEC made by Sangamo whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.901%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.693%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit-991930.htm">Press Release regarding financial results dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit-991930.htm">November</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit-991930.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit-991930.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit-991930.htm">, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.990%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SANGAMO THERAPEUTICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 4, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LEXANDER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> D. M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ACRAE</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexander D. Macrae, M.B., Ch.B., Ph.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit-991930.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="icbc74ea8f67e4a278f727638cbe8f8dd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><img alt="logo1.gif" src="logo1.gif" style="height:100px;width:300px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS REPORTS BUSINESS HIGHLIGHTS AND </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIRD QUARTER 2020 FINANCIAL RESULTS</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conference Call and Webcast Scheduled for 5&#58;00 p.m. Eastern Time </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Brisbane, California</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">November 4, 2020 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8211; Sangamo Therapeutics, Inc. (Nasdaq&#58; SGMO), a genomic medicine company, today reported third quarter 2020 financial results and recent business highlights.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;We are pleased with the clinical execution momentum across our portfolio, including the first patient dosed in the registrational AFFINE study of our investigational hemophilia A gene therapy partnered with Pfizer, as well as dosing of the first two patients in the Phase 1&#47;2 STAAR study evaluating our Fabry disease gene therapy,&#8221; said Sandy Macrae, CEO of Sangamo. &#8220;We also continue to advance our research projects, exemplified by the completion of our research activities in our ALS program partnered with Pfizer.&#8221; </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Business Updates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Earned a $30 million milestone from Pfizer for the dosing of the first patient in the registrational Phase 3 AFFINE study of investigational hemophilia A gene therapy giroctocogene fitelparvovec (SB-525). </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Pfizer provided updated data from the Phase 1&#47;2 Alta study of giroctocogene fitelparvovec demonstrating tolerability, clinically meaningful factor levels with no bleeds and no prophylactic factor use through up to 85 weeks in the longest patient treated in the highest dose cohort.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Completed dosing of the first two patients in our Phase 1&#47;2 STAAR study evaluating our investigational ST-920 gene therapy in Fabry disease. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Received additional regulatory approvals supporting the first-in-human Phase 1&#47;2 STEADFAST study evaluating our CAR-Treg product candidate TX200 in kidney transplantation. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Completed our research activities in our collaboration with Pfizer to develop gene regulation therapies using zinc finger protein transcription factors for the treatment of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">C9ORF72</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-related Amyotrophic Lateral Sclerosis (ALS). Earned a $5 million milestone related to the program.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Appointed Dr. Kenneth Hillan MB ChB, to our Board of Directors.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Third Quarter 2020 Financial Results</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cash, cash equivalents and marketable securities were $694.6 million as of September 30, 2020, compared to $384.3 million as of December 31, 2019. The balance at the end of the third quarter includes the previously announced $75.0 million upfront license fee from Novartis. We expect to receive the $35 million in milestone payments from Pfizer in the fourth quarter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consolidated net loss attributable to Sangamo for the third quarter ended September 30, 2020 was $1.6 million, or $0.01 per share, compared to a net loss of $27.3 million, or $0.24 per share, for the same period in 2019. Revenues for the third quarter ended September 30, 2020 were $57.8 million, compared to $22.0 million for the same period in 2019.</font></div><div style="text-align:justify"><font><br></font></div><div><img alt="opextable-timesnewroman1.gif" src="opextable-timesnewroman1.gif" style="height:151px;width:684px"></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses were $61.5 million for the third quarter ended September 30, 2020, compared to $51.2 million for the same period in 2019. Non-GAAP operating expenses, which exclude stock-based compensation expense, were $54.8 million for the third quarter ended September 30, 2020, compared to $46.5 million for the same period in 2019. The increase in operating expenses reflects our headcount growth and facilities expansion to support the advancement of our therapeutic pipeline and manufacturing capabilities. These increases were partially offset by a decrease in clinical and manufacturing supply expenses. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revised Financial Guidance for 2020</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are revising our full year operating expense guidance initially provided on February 28, 2020 and revised on August 5, 2020 as follows&#58;</font></div><div><img alt="financialguidance-timesnew.gif" src="financialguidance-timesnew.gif" style="height:189px;width:684px"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Conference Call</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sangamo will host a conference call today, November 4, 2020, at 5&#58;00 p.m. Eastern Time, which will be open to the public. The call will also be webcast with live Q&#38;A and can be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Events and Presentations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 2575067. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Events and Presentations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. A conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 2575067.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">About Sangamo Therapeutics</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients&#8217; lives using gene therapy, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ex vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> gene-edited cell therapy, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">in vivo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> genome editing and genome regulation. For more information about Sangamo, visit</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> www.sangamo.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Forward-Looking Statements </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">This press release contains forward-looking statements regarding Sangamo&#8217;s current expectations. These forward-looking statements include, without limitation, statements relating to the potential clinical benefits and long-term durability of SB-525 therapy, anticipated plans and timelines of Sangamo and its collaborators for conducting clinical trials,  the potential to receive milestone payments under our collaborations with Pfizer and the timing of such payments, Sangamo&#8217;s financial resources and expectations, Sangamo&#8217;s 2020 financial guidance related to GAAP and non-GAAP total operating expenses and stock-based compensation and other statements that are not historical fact. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the effects of the evolving COVID-19 pandemic and the impacts of the pandemic on the global business environment, healthcare systems and business and operations of Sangamo and its collaborators, including the initiation and operation of clinical trials&#59; the research and development process&#59; the uncertain timing and unpredictable results of clinical trials, including whether final clinical trial data will validate the safety and efficacy of product candidates&#59; the regulatory approval process for clinical trials and product candidates&#59; the manufacturing of products and product candidates&#59; the commercialization of approved products&#59; the potential for technological developments that obviate technologies used by Sangamo and its collaborators&#59; the potential for Sangamo or its collaborators to breach or terminate collaboration agreements&#59; the potential for Sangamo to fail to realize its expected benefits of its collaborations&#59; and Sangamo&#8217;s ability to achieve expected future financial performance.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">There can be no assurance that Sangamo and its collaborators will be able to develop commercially viable products. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the operations and business environments of Sangamo and its collaborators. These risks and uncertainties are described more fully in Sangamo&#8217;s Securities and Exchange Commission filings and reports, including in Sangamo&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020. Forward-looking statements contained in this announcement are made as of this date, and Sangamo undertakes no duty to update such information except as required under applicable law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">To supplement Sangamo&#8217;s financial results and guidance presented in accordance with GAAP, Sangamo presents non-GAAP total operating expenses, which exclude stock-based compensation expense from GAAP total operating expenses. Sangamo believes that this non-GAAP financial measure, when considered together with its financial information prepared in accordance with GAAP, can enhance investors&#8217; and analysts&#8217; ability to meaningfully compare Sangamo&#8217;s results from period to period and to its forward-looking guidance, and to identify operating trends in Sangamo&#8217;s business. Sangamo has excluded stock-based compensation expense because it is a non-cash expense that may vary significantly from period to period as a result of changes not directly or immediately related to the operational performance for the periods presented. This non-GAAP financial measure is in addition to, not a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Sangamo encourages investors to carefully consider its results under GAAP, as well as its supplemental non-GAAP financial information, to more fully understand Sangamo&#8217;s business.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contact</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">Investor Relations &#38; Media Inquiries </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Aron Feingold                                                   </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">628.252.7494 </font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">afeingold&#64;sangamo.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-more-</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELECTED CONDENSED CONSOLIDATED FINANCIAL DATA</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited&#59; in thousands, except per share data)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:52.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Statement of Operations Data&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br>September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br>September 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,763&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,958&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,392&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,577&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,287&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,288&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,289&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,593&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,177&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,918&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,223&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,633&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,464&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,206&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,512&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,226&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,701)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,248)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,120)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,649)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,910&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,729&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before taxes</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,271)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,361)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,210)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,920)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,508)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,361)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,447)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,920)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to non-controlling interest</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Sangamo Therapeutics, Inc. stockholders</font></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,550)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,307)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,392)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,741)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share attributable to Sangamo Therapeutics Inc. stockholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.61)</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</font></td><td style="background-color:#cceeff;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing basic and diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,100&#160;</font></td><td style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,710&#160;</font></td><td style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,079&#160;</font></td><td style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,837&#160;</font></td><td style="border-bottom:3pt double #444444;border-top:3pt double #444444;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Data&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and marketable securities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694,588&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,306&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963,710&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,516&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520,881&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,739&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">###</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sgmo-20201104.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e4022795-ce74-4d3a-8965-24867b4d211d,g:c6ee3928-e402-4019-a15d-5a85550843c8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgmo="http://www.sangamo.com/20201104" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sangamo.com/20201104">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20201104_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20201104_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20201104_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20201104_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageCoverPage" roleURI="http://www.sangamo.com/role/CoverPageCoverPage">
        <link:definition>0001001 - Document - Cover Page Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>sgmo-20201104_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e4022795-ce74-4d3a-8965-24867b4d211d,g:c6ee3928-e402-4019-a15d-5a85550843c8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com/role/CoverPageCoverPage" xlink:type="simple" xlink:href="sgmo-20201104.xsd#CoverPageCoverPage"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CoverPageCoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>sgmo-20201104_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e4022795-ce74-4d3a-8965-24867b4d211d,g:c6ee3928-e402-4019-a15d-5a85550843c8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.sangamo.com/role/CoverPageCoverPage" xlink:type="simple" xlink:href="sgmo-20201104.xsd#CoverPageCoverPage"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CoverPageCoverPage" xlink:type="extended" id="i2b8e32f0848e43cc9a0480fb4565df1f_CoverPageCoverPage"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>sgmo-20201104_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e4022795-ce74-4d3a-8965-24867b4d211d,g:c6ee3928-e402-4019-a15d-5a85550843c8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_ddb7ab94-426a-40b5-a1ec-a4f2f307b2d3_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_7bb5d3d9-cae1-43c9-85e4-bc5613bd154c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c40fa56d-dd71-4218-aeeb-da3d219fae47_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6fb3d110-b505-4fdd-bef9-9f19e20e8804_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_41039b22-913c-4550-a525-56c953d731aa_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cdf6f44b-9249-49cd-b8a1-81d5c93f3395_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_39723262-a25d-436c-a391-d1e57449b302_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4410d684-0ee8-4f50-b31e-d53ee1bea2e5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b1ae9ee2-2f83-4b67-b8a8-b001361c908a_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c6cfdc25-84d5-4f8a-b60f-27a8ed94df98_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5c9e9d51-51f9-4748-b9e7-9c41103c687b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a712fd04-1fb2-45c2-a9eb-dd4e9f4e4026_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f0f5cc99-d475-486b-96ae-47aadb044afb_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a1bef9f1-69f6-4f81-afa2-a0bbddcc1e7b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5c7db39c-f146-4556-968d-f04d46b7827a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ae5862ae-4c62-4c53-8d48-c9101fd1050a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_70d57efb-496b-4f70-a56b-3d3c99071d95_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_69971fb9-16f7-437e-8486-12a95f6b0c30_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c7b6a3b1-1200-4ff2-bbd7-a5e7310e809c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6dcda7c0-4006-4969-9ce8-21819e19be5d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_b1707101-5a31-45c6-8479-84af36e9f93d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_98b9ae39-bb7e-40c2-8edc-42c00a26b84d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ca949c5e-5c44-4060-ad18-79615548fdc1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>sgmo-20201104_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:e4022795-ce74-4d3a-8965-24867b4d211d,g:c6ee3928-e402-4019-a15d-5a85550843c8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com/role/CoverPageCoverPage" xlink:type="simple" xlink:href="sgmo-20201104.xsd#CoverPageCoverPage"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CoverPageCoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_07f6c0e8-a144-4b77-b4c1-85e15a04edaf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_DocumentType_07f6c0e8-a144-4b77-b4c1-85e15a04edaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6250ae7e-1124-4f17-b292-07db59da3512" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_DocumentPeriodEndDate_6250ae7e-1124-4f17-b292-07db59da3512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0e61548e-3f1e-48eb-a4ea-7ecd8ff95fe1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityRegistrantName_0e61548e-3f1e-48eb-a4ea-7ecd8ff95fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8648cac0-62bf-4184-ab36-b98b25bea5af" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8648cac0-62bf-4184-ab36-b98b25bea5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e4b73fbb-a28a-4cfc-8b26-cd665a5e783b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityFileNumber_e4b73fbb-a28a-4cfc-8b26-cd665a5e783b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_02a05edc-8721-47ec-bcb1-382ccb179902" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityTaxIdentificationNumber_02a05edc-8721-47ec-bcb1-382ccb179902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1f5c314f-7bc9-42b9-8a44-e54d624e59c6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityAddressAddressLine1_1f5c314f-7bc9-42b9-8a44-e54d624e59c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e4e98079-f76c-4d10-8209-030bd503c791" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityAddressCityOrTown_e4e98079-f76c-4d10-8209-030bd503c791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_26636832-4ce6-4b99-876e-62131e16ae50" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityAddressStateOrProvince_26636832-4ce6-4b99-876e-62131e16ae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4281acad-02cc-4f3e-a9ea-c440e80378ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityAddressPostalZipCode_4281acad-02cc-4f3e-a9ea-c440e80378ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e9e4fc33-8dac-4e79-b647-10b8b6c61a98" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_CityAreaCode_e9e4fc33-8dac-4e79-b647-10b8b6c61a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0503cef7-be9e-425c-95c5-73fb1c2f94f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_LocalPhoneNumber_0503cef7-be9e-425c-95c5-73fb1c2f94f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2e2e6a72-e408-4925-8129-23619877d2c6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_WrittenCommunications_2e2e6a72-e408-4925-8129-23619877d2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b3552258-8191-4380-8433-be9d809cdd4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_SolicitingMaterial_b3552258-8191-4380-8433-be9d809cdd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_05a3ea3d-793f-4d19-82ba-5ae597de1a38" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_PreCommencementTenderOffer_05a3ea3d-793f-4d19-82ba-5ae597de1a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_9f11df1b-4dbe-4bc8-9b76-6e5584fe22eb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_9f11df1b-4dbe-4bc8-9b76-6e5584fe22eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7521e021-5306-4880-bccd-edd9d17fa87a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_Security12bTitle_7521e021-5306-4880-bccd-edd9d17fa87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_04969e1f-93a0-4584-ab70-d2f2d77f8893" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_TradingSymbol_04969e1f-93a0-4584-ab70-d2f2d77f8893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1695c91a-a113-4a17-8ff5-7b8845a2011f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_SecurityExchangeName_1695c91a-a113-4a17-8ff5-7b8845a2011f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_74c910f8-829e-4347-a70b-d5ebf4224bf3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityEmergingGrowthCompany_74c910f8-829e-4347-a70b-d5ebf4224bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_19f642cc-cc9e-447f-898e-cd4bc075aa4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_EntityCentralIndexKey_19f642cc-cc9e-447f-898e-cd4bc075aa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_43bdd7f7-fa7c-4e73-a0c9-a9b1979a6cae" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_689433d4-ae21-4d55-8b66-90bc361615fe" xlink:to="loc_dei_AmendmentFlag_43bdd7f7-fa7c-4e73-a0c9-a9b1979a6cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>financialguidance-timesnew.gif
<TEXT>
begin 644 financialguidance-timesnew.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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M.(XQ#'\R'WM*%X1BJU%1"U1#&S#D0C"4L2LTH'_Q"IY00Z' "+E BO[X0KG
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C'O;A'P;B(!;B(2;B(C;B(T;B)%8,XB5FXB9VXB=^D8   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>logo1.gif
<TEXT>
begin 644 logo1.gif
M1TE&.#EA@ -# 7   "'_"TY%5%-#05!%,BXP P$!   A^00      "P
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MQ"$' ;-E-79&/E157&_%98\ENQCT!2N% -OJI%]7 A]P.N3<.%XD-D($ 7F
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MB6 IYM;"23\1YPK1_\3.Z!,P')@DL&"$#P9ZCZ'=7*2R2BNOQ#++AQ K2"$
MK&*@! ]T<DFZD'#"*2WI6D- *@:B1&A*+36:2+>+[)P3(0;DY*T@"BCX (+Y
M?LRN+I1NFHLD,A55T[,SE^HQ._ZX@8$-'&@R2CV0G#OJNC9;U&V@*RBMCTRC
M)B!@ LQ".VZ^- W]PK*VRFP-)$<]BS2"&[J!P0H)HLHASSNK4HPQ!M@(H308
M+K!0.0)ZM*Q(,F]==*3["+SI. @Z"&$>':!9*QP!;Q"7.O32&B%8W!CR$L_=
M#J(H3!Q&&+<UG>ZK+%6GR*4).R#_I>ZF B+%3ZD'1O IA-JNT.H!IS2+M?^
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ME!:7&!@$/#MTVB8I((W;JH=$^  VJ(#P&YPQ.KX608PID9.^/$B(X#$^VRH
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M@*_I( Y:O!ZYOAI2LJ9 BN:2K,P8&-0Q)T;+0;0TJB)CO&KTH1O(1H880\R
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M_"D/0A0&&PE*4&$(8>=6#/*!*,I+1U.,5.> $S&0[ >5*;PI3G.*FC"^1H4
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M0%S/Q[F=H(3=4;"!_,R133S>CT#&60S6U6CD2AFF0:K%)^6(/V GT9!DFWI
M6E4%\Q2:$2& ]YU1"K!!H$J*?/QFLOA#V^$J':H$;2K)R%P@Q!#/-R5/5ZS!
MS'@0T('_U@SM8Z  9) =Q.(%:)[PFE3A3>>P5W9Z!=<H2\-1T?G]I':8DL!)
M&EK6'Z QWH<D2W0M3N!A!+SE:?4!P!H,)D)RY$T\A%U\W;,<!,*<(:.TSDKJ
MHBX*D!9AYP#N5PJ8P"74099>P@HDP)BN@!IT00*$;#_(@Y9N@#Q@ ?*5!P-4
M@#^LG%[B!%K,Q&4TQ<L!9";NJ<\RZU>%!XUTF*ND2$.\U %)3UPLJGTR:@\*
M9TQUS%5IE%9!J,..3I\& 6ME3CU]3?B,B>%%:%2*JOW1&0 58I&Z1_@XQP_V
M&:C]V1H)&D[<32TI$X?F5&:I5!0YGB)VDV&01$"9A,Q,%;+^_\0-6,!>F.)-
MT:']38L58$!-+MUD;)/&Q*$=:=(:Y6RG],;C69 I?53_]*QJ9*%OP5!P"!]\
MV=@B7J$CZDB:=(X_>%!3O*=SK@:-J@<;[:L;6919%$!#-)2/E@: '$V$H95%
MA-N^]A4$U(-&I@2QWF)4A1*3X)(1?1UV[1<1? ,'<$ _8.8*?&D_)(#()H :
MA*^6=NF6;D":%LDSOLA6X  W)-2>4.Y:S<>_\=?/YF]K1A-Y?%0.6$YMIDA5
M<%[1-55P[!!"%E/3(E749DL]S@2GB$I#@51_ <85>%@$#)8Y015QB"1_@!P)
MB2YO-:11-$Q+31BD:K#S8&36',VK)O]6O.[NQMA%O#$N3C%N*W7;A#DI3(T/
M#$9;I!W%N#H/<?A1;]HO!&3DS$%:>IB;_"0&!%)%>?$(1,CE7P +!7A 36H3
MSD;(D5X$! #<\:E0\ [,K4H+ %Q?  E?%_*#UH$>48)=H%W&9'AD#-O,7&SH
M,S[CC*)*">#'KKH1WHR/G>;GP!P9OLV)Q.R&UTKM"+ / 2H% %&$1L!6RDV9
M$6% (E#)5LB&9Y( %AS!!G!O/W0IR)ZO*6OI)73OF);R$<B#)VN8>408\-@)
MNBX=O1R&F]6;_O8RS<T5VXP.G<U#!6@ !(R Z3(JD^58LT6(NXU)B.6,%*]9
M(.,);]0*PSG_9<\ 3)\NGA34AVX8, <;T<]<+0%JI\& 14I]@*XE7(3LY@"=
M7WV\Q:?!" /$K47A1'Q4"$+5AO=-W0T'"P,D@CS=XJ,^B;Y<XCJIQ\P0;N$:
MA@6(F>*BD&QX \+(9EW,27GMR.0^"4&,4,Q"0.1.!#=9U)WH2J\T8I^BT%P]
MBR8=G%-PGFY@5.S>\?%42JB1G*;\$"@]EX/X PY W,N:1K;A'XK,Y&]<A3]\
MG<#REJT5R@=,D>>D24RL'FD)8,.:CJ)@$%O-*I'.A,@TA4B23H 0P0E4ICR4
M\IA^+,AZJ2EC)EROP,ARP F4('<ZKV=Q'K[TL-TMST#L$QCYLF#7_QRX(A=@
M*@0=5$ 0)$(]2 ""*,=75F!6#8]&C*54T%)&_6M).QZM,$>[Z>9[< ?6Z(Y=
M39T(X.#.%>04=L1C.,!88^UHS!M.J98$4(2L(DZJLF#@N5NK)@\#H,$XZ6+$
MNA%5C0 ."""<I5"M-=$'2(!!3X:TWF<,JL09L4$ .1[34"L+?EIH#'4Z<P4!
MI@31$E4WX0P\#EMHW Z2+)#-QNNI2C$?2L 5I!1NX8Y.G<2&D!=<0(_&*.%M
M%.51!)J[DK0T\R7&5C 3H013R-?OH1ME=%U-\7$9$_716#=24>"$=0Q0@ /I
MG 1/[AG4C@@E9A.P$@HP?D-;CVPIM_7WRO^U7*>L*K]XF<I#+>C!);D= ^BJ
MJ459.!3:#$6*86#-9WCW8!>YP(#NV(:PM*2!"&B !]2#!2T*$;%@%3U*5BGB
M5##)S[5'7^42_VT*/FT$$8U (O 3GMH; R") 0E3V/QDGR! I8(F.NN4R?W.
M;EP' 83S4=/1VX+4)FV*5*6NH]P)!'"X,.-MPVJA9]$+&XK;PX7N/?_.9M]B
MJG[!WQYZ0(?W00BFAQ5.>\A'K['%L,'(%="8[B&P\2SD"F77$I<$3U[ 1G!$
M1% $=7)E3J(*#@!3Q>A1QE#*-H)K:S31@>:NK&!:^& $-RAT>*.&@"02%$5L
M,5%1$D*$!?BA!,'_"4-$AFY(#,[DA,BDJ@0LJ[\H ,<>09>.:?FVLKJ/J<BJ
MN%J7;Q>LP!%@0<0!0!1.&-/T6J(2NA@GN9'_NU26#CJ?4@F  QO@P)8@\V/[
MCA%Q7\*NHP5.!4:QYSD>\82]A>3A2U#T>][>,[3>$O@X'T8 !0P U885C0@?
MN77+DC;]Y'WJ(@O;D8#CTOW,4*6+-&/>>*8K1,%Z(![B"1[;K<.&DY)5C).*
M^-/4!AWXXX27D(]";$8$#S;&JZL41'.6!/XUA>8.=WHU1--Y0#1F[)SAJNDH
MV?])\YGDA.6ZETP^AV=Y(:5\0:^ 9K!+BW4'J*?DM23YP[[\!9%3>$DL_Y+7
MACCP=$108.P0KM%BP2,CD\@#3,!HJ6N]E@<1V,$1@&R[J_OXAJ_XAJ_GJ[@\
MJ($:), HFP!WFL<\%'02SA<5B0_-'Q[$+3O S_YJI,IIW#C,^#8#E$ :*#8.
MA(#2U,9C8\)?LV!3O5;OSMTP(35OY'F7Q81R,%-V1LO@),94=,KY"8?O D50
M1USP-OW !(A!T$9>K^)T4H;;VC,>>5)0&K1\W,7)"]GNUP9%+2I7VNGH[/Z0
M#K*C5 5 A'M X,87"5< ) 1 1&%#AP\A0E0 8*)#!A?K(;CQH$!!CU\>;.3W
ML2"""@P4IDB80R/' E\^1@!Y@U_(+PA@2/B TO];PXH5>T84.M2A@HDH 6C0
M")-C09A/2<)$D./B1 47E3)]^E0FS!L>(51(:)6H1)4 4#(0(<'C@R\R;_C[
M\H5  ;LP)9PL"Q$I6;0,2L! ,#="R(XWO_ C4->M!#8_T0*8!\$?S7 %ZA8L
M8-/IC<(;$7BXF#+A%!0K+O7KIT9U@@3]7JM9 5LV;-BSY;5N?>0;0X5'KR"
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M(BZW@RQ"4 378 3RB"8Z3KXJ!S CH#+^[CK(YRC@R,)VT.=N( <7+Q0!( C
MC;?(:"LX)1AGCY^$* 5,X)/@<960#!Y!;\B0\'?FT5A^!P1.P"+J<F9D8A;3
M*RJ0Z"L@H&SRY#6M_W1=H*,O'M U?:,G2D"H$F.C+,L_4.;!8("]1"KC$D<2
M$\,_591$YNQ"P^<H\*PC0D*WP$I1HJHCMF_P--"[*F<F&\4!+BLL7"KA%NK\
MS&@\H<IT)NHHX*>FON_0C",DBDU+L^9"'K&LXF(D+F8WH0(KHV=H/L,9,4U
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M,5=BRS\49ZI&8[0 P X^:7<^\]T4MW&5\+ Z;P7T +("6XIRL'4QB?5@9("
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M1 E*FMVQPA%'4S@%^'>#!'4^QX (%J@E\GL&82 <P"PN-IY#]M*%\5S>O*4
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MI5,"3L,2.V>GX,@G4TIC9K0E9:D=X)%M?!(<;B2%]M%Q0W:$._(>@"DG"(0
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MAP_H +((NBK[P-72+K+ D0Q<M 7(1-6ZPVD*#7ZP@F[PP*20D[1@B'P"KXT
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M#@0%/@.##"(P@3J0CR[(!P[H!PZ0T0F[/N>CL'<]*0,ID.FCT1RJO@K;  X
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M /\;<J"2; 64/I_=K!"?&1%Z3N1-.:B RCY@W ]HX+C&K6T:^N>7!NXN(D3
M:-'NHTRB>.Y_C<+(<-G AB $@;9L ,<[5T,1SMF'H,\% !U* (X@C#<(Q:"M
M"-:0!NNMR%7-U-UNS6O1,3KLK;D"G+)*4D/0?"$V)[J:Y414J#X-M"'-C(N"
MY.D=^-DJ#:.]Y85LECYLI@\&(0!G]:P'$<]Z(V)RI!8*10!?(Q0#ON0MP5CO
MQCB'P&4[Z%Q#!8:; Q/D0 0E9@@)SGN7O;EI.3Y>@Y KT&,G3PN(':S+'Q_R
MIGF@<)U/7@.7AXR@*1]YHD:>""HE18(SPXX*9SXE8"?_@A3T\C;.<FZ5A(/X
M1V^0+&])7L[VL)S."B!7 X(>-*%)FUPV]'@-%>V=46 99T"]I"_;8[0(,5PT
M!JB8JC?FRU\PZC5(>6=MP5TTP"9-E+[ 6346:9,YUUO%!5VDKXQ30)[WPLS>
M_M%SW7')I!^Z$'KFX KVHIS/+#<;C0F$AAXZB8TQ_56]J2V[ 5X31N:1AB"'
M]P/9#F]Q;1N?13]L;T9U"(;?>N)H!O2/>@XH$#/J9E=:A* , N%_ 9!BF,8E
MDAQ<T&ER_+57^V7"JL&LGG_;$M!Q&B^IGC/#&Q[3__6VX*!%C?]ZS>>+5W<B
M<'RVPU]B\8S/V47EKCAG\5V4_X]'W%KQQO4K[>*H"ER5<IA9S -.M+POA ,R
MA6)@X][WV96#O-%U(;G')Q[TE+MZTI8..,0U7MV-A]IHVJLWQZD,DXA9G.C_
M$WB"?&O=OP[=U1T?.]GILO"\]%KI 3YZT4U>]KA4N>400WK".;YQWG+]TDXO
MJMOUR_*^[[V!W T,-_@3+MS8_&K^F3D"0@!NP$-R[>L%^UTDS?8%.1K +7+)
MV9N>=UC#.O.N?%'N6IFTNTL<P$M_.^M;/^;*4MB9=;Z\G#M/88F*6N0@1XJT
MXYYW%HE9[.]>I;H?_OGL"1SJ$EM("8+ M"_L!C?FT5B."., "3!I.6V"-&@?
M?O7O\_\][G2!%.>*/ZNC6!W\HR<SW(>OZN\?O^F:17W8<^OZ^^,_U57.M._5
M'WY-SP[\\([]Q1G7P5[!V1Y%<5I],*#\N8JTX8[Y>9W!46#3.5LK<1U^]-H?
MX=8'/ <,0(-NZ 8!4-\#Z,0,/=$'_)O_X<5?X1[\P6#F[9__Z1L%MDFMA1L+
MXEL#3AC0C=[G22#DY1O[H=]+B%_'H5<J@=[JX5\3.N'!_9:+<%T/.F 1=EQN
M[9I_Q9[[P1K]P93HU87M62#Q"9T.WHX79ASJC1N?!0:X1, $3-\O?<2.($D]
M)(T5TIYUO1NK )VZ"9R++ X?5J$/0B%$-1/W">'Z&:'MZ!__W<4?VG5?W>7%
M =[A$UHB!M(.#]I9U0VBW$V@G!WA7BB(Q.B>W07=([8<()Z<[1"B(;9$XLB4
M7VG>7CQ0MB2"!!B>N7C(\WG$S$7 2;342KP4&NJA#A(C$:Y<,Z$>:HSBWRU'
MR/BA%W;),;J?%$:<-:X=-0JA(/:AY,GBGUQB.-Y?$!:A,D:B7:@= 28BPXE?
M0\35^SP$R<35Y#%$,L*$.NY=VU5@P@$AZ%D+RBF.>C&B41RC1?3%&A*%"' 1
MSA5 SK4'<2#+\4C(X;"=-M+=M%GD.2Z@R7W<[ DA.0;=QF4D0")?ZI4A*J87
M#&[B.GJC$.V:KHEC3&8B^*GB1?K:=%UD)/>%8IPYF_E-&'X '1-6(4&FH7E1
MW"+.XC.A9&ID)">^(#W>(7YM'4M&FC/678YY  1,R1?T1G48QG@(RW6H8 5F
MH=&H5P,%HL%!'=(1(S1>T>8)7S&VX/AI9$M.XER<91XJW#YVI+W]W:K9&Z9=
MH$G*_V1AAMP0VII<VN3;_>'5'26^?5Q0OEU3XAW ?$VCF! )G= )-<J_ 0I+
M4,!2MDH.X"*5)!X241\&.)Z?/%(@P0IEHJ%H&N9LTF9MVN9MXF9NXN91+1^]
ML! &O(QXP( 'L% B:,"["-'/U4[RE8 'W%S90*='.(!"$(44BJ%N8F=V:N=V
M<F=W>B=W7A@ L,$:(8 4>!&&H"=*H,%84>6K!%)@Y,1Y1"?TE4U[W,T J@T^
M?N=^\F=_^N=_ FB OF8%(,1KH%%[!(?3(&@>0  #:1QEVAH#B  WS$;B,1@_
M+)'SW,UGU9EL"NB'@FB(BNB(DFCKR5%S$D>9)!*P>,@O2O_/&B0=&4)$#A@H
M$F'&N<PABS)5]JT8!4)HB0)ID KID!)ID:H> U0 )DCGU%SH#&7&<$B 5-63
M7M[E5SE.:#"1L&2H1UA!!4!4AQIIF(KIF))IF88H!; !<?A'9N2<"3XI#26&
M8%P!>VZ:*B'-55$?9!A;;1@+]OG),P:*F0KJH!)JH1JJZW&)<X"EN/0'260&
M <R<EDP$#LXD097 +08.??[&I@I+F3A !:QA=7GHH9)JJ9KJJ:(JYXFG!#1&
MS1% 2BG&>?"&1"I$?A'F<OY%A.@,B02)CE@'&]!'C]Z8?J9JL1KKL2+KF#(
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M30S0[!8(3Q;#3T*BPV)/(31C?Z $4+JM>FP.9GJE9_KC:_2@.^S-?18"04!
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M!A^_#]-<A9BPT!OM0#UD[XPZR>]B8RH9 \[,)N1$(I=FPVI.XVA(0#.Z8,[
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AW=5?'=9C7=9GG=9KW=9O'==S7==WG==[W==_/7 " @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>opextable-timesnewroman1.gif
<TEXT>
begin 644 opextable-timesnewroman1.gif
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MS#.J_S/5 #/5,S/59C/5F3/5S#/5_S/_ #/_,S/_9C/_F3/_S#/__V8  &8
M,V8 9F8 F68 S&8 _V8K &8K,V8K9F8KF68KS&8K_V95 &95,V959F95F695
MS&95_V:  &: ,V: 9F: F6: S&: _V:J &:J,V:J9F:JF6:JS&:J_V;5 &;5
M,V;59F;5F6;5S&;5_V;_ &;_,V;_9F;_F6;_S&;__YD  )D ,YD 9ID F9D
MS)D _YDK )DK,YDK9IDKF9DKS)DK_YE5 )E5,YE59IE5F9E5S)E5_YF  )F
M,YF 9IF F9F S)F _YFJ )FJ,YFJ9IFJF9FJS)FJ_YG5 )G5,YG59IG5F9G5
MS)G5_YG_ )G_,YG_9IG_F9G_S)G__\P  ,P ,\P 9LP F<P S,P _\PK ,PK
M,\PK9LPKF<PKS,PK_\Q5 ,Q5,\Q59LQ5F<Q5S,Q5_\R  ,R ,\R 9LR F<R
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MR\C@4I?KE SGH%7'J>&&$/54SCJ+V3E &I0J#6N?A-YXO0#]B&$%U1<D.24
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M(0]&V76]DYASL:6)Y:6A :9Y<6[@U!*@V2X5$1P\I*8747<PH0^,P*5\D1Z
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M1O;IHT*P8# !T13.RS%1Y$B2)44J I!2)8 X\U:$,L@N $R#+D_%G&ER7S
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M")$MK;=<7)&@%BT[4B7GZE+)(ND @*"<E-S:$@ M4X(*HY3$\.\3*E(:T4P
MT S AI0>\!( K]R, ;^"W$3#OU#PG(DG.Y.)D:4M$2"4S2TAX''00N/0AY@U
MP]K04#(]<A/.4(YLZ=$]#2$,RY1J4[)44T^5*$S!5F1S3RJF FLE,5%%5=50
M]XS-U:FLL_-66G]EZ#.57#QR-/Y.B74E4H%-$C8=6:7TV Y;9;9::Z_%-EMM
MM^6V6V^_!3=<<<<EMUQSST4W77779;===]^%-UYY6^>EMUY[[\4W7WWWY;=?
M?_\%.&"!2Y2U8(,/1CAAA1=FN&&''U8)(8@GIKABBR]>N"2,-^:X8X]7DOAC
MD4<F.>&!3T8Y99579KEEEU^&.6:99Z:Y9IMOQCEGG7?_YKEGGW\&.FBAAR:Z
M:*./1CIIB52LD6FEGX8Z:JF[;536*Q72![*%8H6RN*P)<WIJL;%><U4>N_;-
MRI3#O/KLV0A)2<^6W8Y)5NVJOIHBM?FE^R"V$_H-(6']O"T8@F2"B9UEC32-
MH;")FZ?QL2=_""79+H*;TH\*E3O@*O$;O&O=;OJL<Y1#]UM6KG8)@'30-H][
MLGM1/^ASV7FLX+5"7#<]LUX\0OPB2AK2):^%&#NQ>%\I9]ZWWI%/:!'93Y;^
M> Z-M$J@O%5&/I^^VM.(%L&"N=R@Z@&&?I_S$YH'!RW*5S![%;9732;H#,+[
M.Y7"2U:CL//7"Q6 P",]-6HT_XI(@#"F RW [&]#4LH1I_8$M]Y%A4RG&-P#
MP+(K 1)P*09TW0,DR*H'3&(\%YQ6"9?7/&R!Y4-&NAX,N:2R(\'O@0^9DLL>
MIP\K$ 8L%N'A\FH(,!4-D316@ 8AO-.0'-XF>.UQ"UB,0@\,/0E$!()2%<'R
M #/%X B?(4M%,)> ) *@ 3IH"C3@(KYH4#&*;#)3 TS#QGWD*E;/ A$0"0&F
MUND#5%W\(B'"J$<$J-&,<_1*/KK@$7F 28^)7.0^&KE"%E8+-@E 2:]J%\/4
MQ0YE8>K<XVHGN98]CAU7$]1H].;)?JD(E).IGF,<$CE*:N:)-\P/3 (SI)MP
MQ"-S>?\A+G<RD\\L\2_S8($/P^)+7NX$*N"I"8?HB"'KI"8Y1F(!=)STF00L
MH@\3Y,HQD]DA@DS3*Z[Y'3*5&0?&_*Z2VYH+#F REV<!TR$;K*6_\+G)8"JD
M%O<K)2<-\D_F$(XA^^27/1."T%U8DTD.(2AQY*&G6SH)0*DC"],JRI+/.(<V
MR<K2/LRC-[)442\<@@17(@04S)4/I*-RU96N^18CO'16*;T+F& *+;5M:7'O
MM)92VJ,G41HD?0.#7E$+@[:4'54OD=Q3@X3%U)-2=5Z/VTL^U( K/"*$'5;-
MS$:MTAF3HB0.S-2HYCJC".=8!PCLH$Y"(F00LS)SEWZ19N[_1.H6#-'&JW%E
M7QBB];H OA6P?DO073$' +0<MJ#: >JU;(*3I2BU((KXJ< PNTFJ@D1F_R-5
MKNKBV(1L-J$"]8U%,BFKKGF61+<42).@DAC1G(4JG(SM4S!(6)L(%2$F-4Q6
M]M$6L$E3I6YQ$_Q\>Q!%1B-$^V@.+Y=KD-X,1A_?.^90?H)=U$:65AW5K5&[
M^Y/=K$PWDW'J8B37CNFA+&SEY6I,5J6[]MHKO?K8@NR.<[SUUC>LK4N=0T.#
MH6&X!T3K$:AT!(PYJ- BKL\ESUXK])YG>D5#"CT0-,_;$ A#RA AC 88/>+@
M$=^-.TN$)H,<1(C4=%C%F .K=Y6T*DT!X16LM!"2RG ,0[15Z4OY]-R-$"(/
M4EH0@IFM2X[W];@=)R1'L%/)?/]5(Z@>M6=8T>3HI."D)FHQY<J7Q4&,5A6F
M,3$64UKVDT!84J4X;.D!C2)CYE"XREE)QRB"(J,BPJQ)4=5Y3G5*P#,DU64R
M7V30FI.QM?K724T>:W"(#MBC762KM\"J8$@6&*4- HDL[LW1<HYQO"@M::R)
M]E@VQ?2X9HHB6]QO'ELER6>4G&A:U]K64HLNBA17.SB8)->W!G:PA?TS6=/(
MP!?16JS9.FQF-]O9,'-35XM3M0KB<%(V?':VM;UM;G?;V]\&=[C%/6YRE]O<
MYT9WNM6];G:WV]WOAG>\Y3UO>M?;WNG^#+:-*L#5"!==EKTW9A01ZJU)&V #
MUPE<889+\,THO%\,MZ7!<9BYMVKD:R(1EL3?,JO-2 >RX;JX, -N',+NF\]U
M6TE)I>RO5=-5VB]5.9!97G(C(Z11U>[;8/35\IP?1)8+R;E)_R?BF M1BI8D
M.5"P"!&$U3!S7$<?.8E,2]<9*F2U*9$--#6[.![9\.I51Q#+IDZ[^0#/=&2?
MC[[&GKFN=1UK;+>YOF?#[XV$SW@BT87&,9=JDRQG7)"X>]2=.%]:5-![3+$*
M; @N+W9(.1\R $-7#P\^ST#\9(WW%?*:2$?@<%+Q^,(\:03Z^,@S)'V?ETA]
M?$@0*J]N;_HSJ!WG])KF>'!:E+IC)D[(V/ME,@8?AWT!7X_ 9ZS)*"C)B5OO
M\T$4?D:$,5++G$S(0 O.GCT U(<6G@]IV.\G<QKDO5MMWWW2:7^$=YQ^]54I
MXY8["2)!/$A@9#ZOENL%B4IT"/SQM__R?]5?F/+0KL( ,/81*/FS%_]CFGRX
MOR7:'"@Q0(D0E*MQH_-X(ZY@(S"ZB;R["%!9"$7P(@RTCG*").!QI#$:L3MY
M%8"ZHA 3I%ZJP,%!BSB!%,?HHB# P#S"G$):$SERKA&4I$1:(Z]0!N)B%8W0
MHNF((T3RE<WBIA'KHS]:DQ@P@AMDPCTJOD/JP6AHKA\<,4*:O[%I(N?+)/Z+
MB;RY)7YIHH*();T[):^J-C2LL6@:*Q50CMYQFC.4ES2T,8180\<1*#Q\B$7[
M#L5@#_>8K,* BN[0AP9YFW :B,GR)=<8AJ08IR@1"NAPNF9"Q*2X'@,C,2NB
MD&*R,632IK#_,"=.U(A)A,1GTI'.*,3TX*OY4B=R&B-O J=1K$0G.45THL1U
MHK7EBJ=Y4@&-BRCQ6KQWF:X(RS>(4L'TZA< G!Z%PAS\4 3@VT/1.\9R@48"
M'!%E?*B%<!IG;(@(+#L!7 H7\CN_.8#QFBF_PI(P2@GG0+4B24=$5$&QTKD0
MS*D06S::0K5]P*GATJDJ2QO[$(R]P,> Q(M;^<>WD"G"^JA+VP<-%,@1VZF&
ME+%;6JYC PZHDL-_T<A>:PR-VT+.0AE 9!HY.SGF$BB 2Q= 1)YY$$EG,;V6
M'*_7&)X),DA:M#% =(QJA [;F2GK8#KI."OM$);&\A5_*Q*QZ!SW_[NAN\HA
M#2,LMX*KY7&P0?0,N$E$EN"(FQBI&X+*SJ %O5(LL2 MOQ LBR,$(;'*M!0M
MQ4K*KTC+1 /&%;@?0/R.Q7')>%FN,%D)M-D%OKS))0O CU2(]'*:OCR7Z;I&
M$#&8UK))@O.C4%F.D<JMVHK)OL@[C-"W7+.)X-J/[ZD*QW2_>MS,S-S$B@3%
M*EHZZ3K,@JBNOB+-@1#-"Q&,!5$!V1JQX[H5QWPJY](.T,1+X)Q-I+BN48Q-
M6M/'";J2>CP(^"J+-ZR7YA0<T5H(Z:2LTXG#Q4 M=VS A:+.==%#D:L\?;O#
M\?0,+2@3_!L,#5&PO:N+ 62$^# *J/P)+?_ CF7TQ(YXL<\H)Q/CCZ*3F\*#
MCOJ$S 5#D #1"/D3,1!Y,!.K(Q0+C_\DA+.RD &1D T9COB<J0R3L@[S(Q![
MT$_LL#HRRPIEQ <YL/'(1JAI/Q;I3H,@LN41.C2DN8-XLH6H4;DBPWY!P (D
M2(6 D2SZT78)TGXJB!TE4B%CBB--B$Q(+BPSPB_KLW+ZDF>(D?7#JYW*%/\P
MA4.SBD+;. #(D^D)$ZN@LBIU%$7Y$FC0,S$+E4)S,T 3M$F1$C2;"37K%&I9
M4U&!@'7X,3H;DSM[TS@].3K%.D"#!DW T[39*5H+/92+EA2D+B@!T("9U)\0
MK?JX'UW U M5F4USA<Q!-9/YDI92/;E,O1=2U;3SU!7H>%56#1K_.Q=;9;>I
MHPQVD+M\T=6$ZU5_^=6&"U9W&59;*E:<><UV659Y^S63N*B!>=:2B-:5F=;,
MJ%9\N5;,R%:@@0WZ,9=OK3?#23B]XQ=R[3MS#1ATC3A_8=>P4O]7G)E2=9E7
MP;/7>\77I"F9?>77D0F9?@78@*48C1'8@C58A?G7@U78A<W7AG78AX78B)78
MB:78BK78B\78C-78C44:QN38CP79UWH]7EE)D[ =7I"=QV&/1WN]$PDYCP4V
M??!(GY'9+Q2:FJW5F1T:,QF1=XV.P>H<E# XZ< CUR!:&@F.<GLT<.V6OZ$(
M; .@RUC:<\E*P2F;%7+:$IG:;>DY5;V2F_.OT<J,K=66KA5;SU@3:\0?[E.-
M?!@#12B@%TV(G-.-;S(J*[@$:U3 O+V5'((-]=P,!%+:'(&&15J'9*T6V[$Y
M - KFP,P7!T)YRO<:#C<<N$1!L02].3_G+!5#<DU7,3]$;2K%(/2.KW4'\RE
M#,^E7-#U$=$]W8^$SL5BV\W0AS%(U76P"NR+(.@C&]+Z*J: @+F8M9T(WABR
M3K.:V[T1/X-2/^A ( 7BGRNKFO#H#.<;(6&I(!#*H TZ!>LP@O%K7LS9ONB;
M#G<*7Q(R7WQID>;2ATD8E_4Q$O>Q(<XC'ZG-"/9UWZ=SGV>!V["%7Q-9WT5J
MWVU)G__=//YK'^W#C  .L?S-EJ-*8!T)G,#!1N+(!S)8D=5IT 21(E[AP4_T
M*K";C=WP3,$A82JX'+\EA '$G[CJX"@,I$$:HS)J@!QH"S4J)^J8P"),0N>*
M*]D3X3IZ)"?$Y" H-%.+:$$<Y*8K_&#ZB*2K5.(]TL(GKDMZ<8S"+1<C8JX%
M5(@?NH@>$K@'P.)R4< D8D 7:@@M/I$K[@)O*:(8N9SELA_@X.(P'F-N2< Z
MKJ:K"$_<J-V-Z!%R?<7WB,7E\6(KF[W" )/U"SWUN)\<XHGR&>0Z2I#2K$1Y
M6";M$*JO9,VJJHM"GI+ZFT5)8I$]6H3A6,:J&F5,%D'<1,6"2*=<9(EVLMEV
MD0XHS997.H@^5(A44L'*N.5:KI980@X$&D.L5 G [;B2Q1972F::F(LZG!Y>
MQHQ@[A:F(>;'G*CV@O]9DKC@M#FKPV%A)P'1+@YB\*2%X<!/15!GS2%9K!//
M<^2HMEP,*J@IB0S+@L2*&7&-<O;>E@IA60D-\!37 +IG@9Y0K2S5T/A'G^H_
M2RT7AG(H;,->SHTUB Z7AA)?O)*G#9$XA')9C,X6:2P+,YM&FJC&I9QHVA7I
M9G;2J'"H!)%C.WQIUOAF5PF ,#@<=Z8+BEQ(VQ&(CV.IT76@+ET)'2G/DIY#
M2,FUCUHYH3-*9C(IU_!I4+;G(>._?-@"S6EJ>R;5LR7"Q>J(27H[D^87M\5/
M<<DJ6*/)UY JN)%;TQN#M.86K<*5< I CNR\N*8,M)Y=8,$J#F%9680U2M[_
M#+_FZQ-A#[MN#*Z0C.WD1N+X8RQ+C;G@S3I:G;KD$5*Q#B$93+_1CF"X&EW0
M#NO<G#/NB)E2BD.,OQD1S9N(5@Q;'>2Z-O993GW@ N'$%$5@.@5Y"=:F*PK5
M0NYJB=A,3O-4WT5JRG$1HZ_KLKJ0#1"66N56VUR.S,=VRK ]5LFF;F'V$5$2
MHPIFM, <V^[6%O8 S&&Q3DZ.;-P "8:D%*/$'.>@R!M-'<%@J5'V3J/0[PUQ
MQ%23[YD2I!,L,1?MY/[T".*Z, ZAR'*@C@UC"!'-[<:XDP%?P185D8E,D+Y:
M481SL0Y/;%4;GN:2"27U%OS2+^RL/!WYZI+0AQ%7_^X ,'%NV2_Y?(Y@T4[)
MAO&OD'%MN:_\LEI,JW'+>/'@+'$?_T[LK"X0P39QO(S5&I%T1F1*R20(P#,_
M7 F?,!/\J)(&B!$N+Q0$ (-G'L<ORSX?B)'#6BW5NI0RU11.43-+X1(\*R.5
ML,8UATRC@+,D0O/I"!4\7Q0XRP='[3(\CY1'U9<0Q&TUBE=L:3*$8-+X*V6^
MBPA%YP)&-Q<FI3&J>G02L71,/^_NZG0+8MI;O(Q/IX)&5Y+'85*A6FZ3[)F"
M1A$$]8O"'HE^/!HW62"0 [520PZ(IK)2C]Q)V75R&7+JJ[3=LE( )G953Y)1
MZW576<E4=;FQ;?9M>=6[WG<DWHO5/L/EF*%G72,5F73Q'#4:G/56G7T:="<V
M=<=8\$*18PNYR-W6D+7W>S_ VD81:K/HN8-G? ?X@!?X@2?X@H_8A45XA4W8
MA&=X?B78AH?XDEGXB*=XCC'X=JGXC.^8B=?XCG^8A_?XD'<8CA?YDC>8BT?Y
ME#57^95G^99W^9>'^9B7^9FG^9JW^9O'^9S7^9WG^9[W^9\'^J 7^J$G^J(W
,^J-'^J17^J4/"  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>sgmo-20201104_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgmo-20201104.xsd" xlink:type="simple"/>
    <context id="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2020-11-04</startDate>
            <endDate>2020-11-04</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl80L2ZyYWc6ZDc4MzljNzY1MDhkNDg3NWI1ZTVlMDU0YmNhMWRiZjIvdGFibGU6ZWJkYWVmNTliZjgwNDgzYTlmZjkwZWY4MDkyM2M3YWIvdGFibGVyYW5nZTplYmRhZWY1OWJmODA0ODNhOWZmOTBlZjgwOTIzYzdhYl8zLTEtMS0xLTA_9826437a-1e2c-4520-976e-b4ceed4088d5">0001001233</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl80L2ZyYWc6ZDc4MzljNzY1MDhkNDg3NWI1ZTVlMDU0YmNhMWRiZjIvdGFibGU6ZWJkYWVmNTliZjgwNDgzYTlmZjkwZWY4MDkyM2M3YWIvdGFibGVyYW5nZTplYmRhZWY1OWJmODA0ODNhOWZmOTBlZjgwOTIzYzdhYl80LTEtMS0xLTA_95b2eb4f-4319-4aad-8038-1b2ace49b119">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl84Ng_2dde4df0-2bff-4ccb-ad8b-007c65af9146">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yMTk5MDIzMjU4MTY2_cbc41239-0fa3-4d80-9cc3-e1be389a5fc4">2020-11-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yMzg_3b3566af-0939-4468-8dfe-ee2f467a2a42">SANGAMO THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6ZjEzMGIwYzQwMDJkNGRmZWI0ZGRkNTRjODdlY2RhNjgvdGFibGVyYW5nZTpmMTMwYjBjNDAwMmQ0ZGZlYjRkZGQ1NGM4N2VjZGE2OF8xLTAtMS0xLTA_7ad9bf76-f151-4bb6-a710-659f2a841ae7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6ZjEzMGIwYzQwMDJkNGRmZWI0ZGRkNTRjODdlY2RhNjgvdGFibGVyYW5nZTpmMTMwYjBjNDAwMmQ0ZGZlYjRkZGQ1NGM4N2VjZGE2OF8xLTItMS0xLTA_c24bb2b0-5ea3-4c18-ac81-c2b21613b62a">000-30171</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6ZjEzMGIwYzQwMDJkNGRmZWI0ZGRkNTRjODdlY2RhNjgvdGFibGVyYW5nZTpmMTMwYjBjNDAwMmQ0ZGZlYjRkZGQ1NGM4N2VjZGE2OF8xLTQtMS0xLTA_900f044d-1ba2-43ff-99a7-95320fa1a5e7">68-0359556</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yNTc2_87b69875-8953-429a-a697-a2d631a32276">7000 Marina Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yNTc3_887e087a-8895-46a0-83b4-96cefeaa35db">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8zMzE_456403b8-e420-40c5-9a4a-927fe012f6b2">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8yNTc4_4ea607b5-4644-4161-b84d-de23038f2a98">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8zOTQ_603a9e8d-9a33-467d-8473-65997b048e62">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8zOTg_363f91f6-ddb9-462c-b3d1-8e9ec848de48">970-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Y2FjNjYzNTIxYTA5NDBhZDk4Mjc0ZGE4M2FlZmIyOTcvdGFibGVyYW5nZTpjYWM2NjM1MjFhMDk0MGFkOTgyNzRkYTgzYWVmYjI5N18wLTAtMS0xLTA_cc643a71-56f5-4669-9f1e-ddf62e927558">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6OTU0ZDA0ZGVlNDk1NGQyZDkzZDY4MzQ1OWJhNDEzMzEvdGFibGVyYW5nZTo5NTRkMDRkZWU0OTU0ZDJkOTNkNjgzNDU5YmE0MTMzMV8wLTAtMS0xLTA_f017e7ae-f984-4e05-b313-1d7f758d625f">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6NjlhNGY4NWY0ODFkNDA3YTkzMzI5NDkxZmQ4NThlNDkvdGFibGVyYW5nZTo2OWE0Zjg1ZjQ4MWQ0MDdhOTMzMjk0OTFmZDg1OGU0OV8wLTAtMS0xLTA_51a5eb70-98b9-4776-9e92-7d35c655a77d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6NmMyOWM5Zjg5YjdkNDJkZTg5YTNjMzgwNGY3MWEwODEvdGFibGVyYW5nZTo2YzI5YzlmODliN2Q0MmRlODlhM2MzODA0ZjcxYTA4MV8wLTAtMS0xLTA_01f4fe63-ba16-43ec-9f9a-a4fc828f9f94">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Zjk0NmJjZGQ5ODNkNDVmZTk4ZDA0MWE4NjkzNWU5NjcvdGFibGVyYW5nZTpmOTQ2YmNkZDk4M2Q0NWZlOThkMDQxYTg2OTM1ZTk2N18yLTAtMS0xLTA_5ab96040-29fd-48a2-90d4-05c5668c89a6">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Zjk0NmJjZGQ5ODNkNDVmZTk4ZDA0MWE4NjkzNWU5NjcvdGFibGVyYW5nZTpmOTQ2YmNkZDk4M2Q0NWZlOThkMDQxYTg2OTM1ZTk2N18yLTItMS0xLTA_aeae7609-05cc-4224-9a76-52047445119c">SGMO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGFibGU6Zjk0NmJjZGQ5ODNkNDVmZTk4ZDA0MWE4NjkzNWU5NjcvdGFibGVyYW5nZTpmOTQ2YmNkZDk4M2Q0NWZlOThkMDQxYTg2OTM1ZTk2N18yLTQtMS0xLTA_38d79d07-69c3-4346-b2a8-b00cf53b947d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104"
      id="id3VybDovL2RvY3MudjEvZG9jOjgwNjdiM2I2OGJlYTQwNWZiMDZmNjVhMGEwMjQzNjVmL3NlYzo4MDY3YjNiNjhiZWE0MDVmYjA2ZjY1YTBhMDI0MzY1Zl8xL2ZyYWc6YmVjMzE1Nzk5MzMzNGZkMjgxYjJkZjZkNjZjMmJiYzIvdGV4dHJlZ2lvbjpiZWMzMTU3OTkzMzM0ZmQyODFiMmRmNmQ2NmMyYmJjMl8xMDUy_149ed3db-09e0-45f7-8d72-ceb94408d40f">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139625783252664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 04, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  04,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANGAMO THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0359556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Marina Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">970-6000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGMO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001001233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MZ*%K66\=\+H/@Y1DZ>ETSQ07FA:9'M2#PIY49M"8TQ-E1=88O3.O:21\*5=
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M,:@W6]5C6)>E:H\_A?<HN9\;[O\2Q0]02P,$%     @ VX!D49>*NQS
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MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( -N
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -N 9%'(70]4/@0  $(0   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " #;@&11@ZFE ]0!   R!@  #0              @ &"#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( -N 9%&7BKL<P    !,"   +
M  "  8$.  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( -N 9%'E:(KL.0$  #("
M   /              "  6H/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" #;@&11)!Z;HJT   #X 0  &@              @ '0$   >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #;@&1199!YDAD!  #/ P
M$P              @ &U$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #_$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sgmo-20201104.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CoverPageCoverPage</Role>
      <ShortName>Cover Page Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sgmo-20201104.htm">sgmo-20201104.htm</File>
    <File>exhibit-991930.htm</File>
    <File>sgmo-20201104.xsd</File>
    <File>sgmo-20201104_cal.xml</File>
    <File>sgmo-20201104_def.xml</File>
    <File>sgmo-20201104_lab.xml</File>
    <File>sgmo-20201104_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sgmo-20201104.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "sgmo-20201104_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sgmo-20201104_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sgmo-20201104.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgmo-20201104_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgmo-20201104_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "sgmo-20201104.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sgmo",
   "nsuri": "http://www.sangamo.com/20201104",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20201104.htm",
      "contextRef": "i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page Cover Page",
     "role": "http://www.sangamo.com/role/CoverPageCoverPage",
     "shortName": "Cover Page Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20201104.htm",
      "contextRef": "i8878c61b6ef04040b617dc7301b3b157_D20201104-20201104",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.sangamo.com/role/CoverPageCoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001628280-20-015492-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-20-015492-xbrl.zip
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M4C?*Y#LZ#"8'7P5 ,*23&.RR\H;RD$A(@?T7PCYI+8#'9YX-K$G4&QU1;HM
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M-@$4@*AA[.OC$#[TZ-2,]/LXXNO;;A=%*>E59\Z(^ZZ#)%8P(6Z' U,0;Q(
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MM-(-98<=2AS@3IB#XAIPB\FVE[[T0,4)4;EEDZ;%#4XK^V26T@7M!G,&<<M
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M&/C4FF9R<;<,0MZ__";JK]AM7+Z,YXL)QG!S-:'QC6,.K0D &%&T.53?.3G
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M!_D%<>_0>#5ON-L.TCIC7^7N"/:&9_#F>^><MH;-%3 ;_0!02P,$%     @
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MGMN-RUN+/N6?\^QGK(%.?4H#''$*L1\%D+B!@B$)?8@=1KW(YTBXJ-..XZU
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M_JO;+_J7_NG]_5?_!U!+ 0(4 Q0    ( -N 9%$D"_GGP1<  .OG   2
M          "  0    !E>&AI8FET+3DY,3DS,"YH=&U02P$"% ,4    " #;
M@&11&1]9 R$6  #EIP  $0              @ 'Q%P  <V=M;RTR,#(P,3$P
M-"YH=&U02P$"% ,4    " #;@&11#ZZUAI$"  ">"0  $0
M@ %!+@  <V=M;RTR,#(P,3$P-"YX<V102P$"% ,4    " #;@&110H9@^88!
M  #K @  %0              @ $!,0  <V=M;RTR,#(P,3$P-%]C86PN>&UL
M4$L! A0#%     @ VX!D45HN1,\* @  G08  !4              ( !NC(
M '-G;6\M,C R,#$Q,#1?9&5F+GAM;%!+ 0(4 Q0    ( -N 9%$'DP)U@0H
M ,Y>   5              "  ?<T  !S9VUO+3(P,C Q,3 T7VQA8BYX;6Q0
M2P$"% ,4    " #;@&11"(5K6JP&  "+,0  %0              @ &K/P
K<V=M;RTR,#(P,3$P-%]P<F4N>&UL4$L%!@     '  < R@$  (I&      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
